Eloxx Pharmaceuticals Stock Total Debt
| ELOXDelisted Stock | USD 6.12 0.30 4.67% |
Eloxx Pharmaceuticals fundamentals help investors to digest information that contributes to Eloxx Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Eloxx Pink Sheet. The fundamental analysis module provides a way to measure Eloxx Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eloxx Pharmaceuticals pink sheet.
Eloxx |
Eloxx Pharmaceuticals Company Total Debt Analysis
Eloxx Pharmaceuticals' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Eloxx Pharmaceuticals Total Debt | 13.38 M |
Most of Eloxx Pharmaceuticals' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eloxx Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Eloxx Pharmaceuticals has a Total Debt of 13.38 M. This is 99.51% lower than that of the Pharmaceuticals sector and 95.88% lower than that of the Health Care industry. The total debt for all United States stocks is 99.75% higher than that of the company.
Eloxx Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eloxx Pharmaceuticals' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Eloxx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eloxx Pharmaceuticals by comparing valuation metrics of similar companies.Eloxx Pharmaceuticals is currently under evaluation in total debt category among its peers.
Eloxx Fundamentals
| Return On Equity | -6.15 | ||||
| Return On Asset | -0.73 | ||||
| Current Valuation | 30.28 M | ||||
| Shares Outstanding | 2.75 M | ||||
| Shares Owned By Insiders | 0.59 % | ||||
| Shares Owned By Institutions | 37.06 % | ||||
| Number Of Shares Shorted | 21.48 K | ||||
| Price To Earning | (7.94) X | ||||
| Price To Book | 6.31 X | ||||
| EBITDA | (34.42 M) | ||||
| Net Income | (36.06 M) | ||||
| Cash And Equivalents | 30.05 M | ||||
| Cash Per Share | 0.35 X | ||||
| Total Debt | 13.38 M | ||||
| Current Ratio | 1.62 X | ||||
| Book Value Per Share | (7.46) X | ||||
| Cash Flow From Operations | (31.84 M) | ||||
| Short Ratio | 0.20 X | ||||
| Earnings Per Share | (12.93) X | ||||
| Target Price | 55.0 | ||||
| Number Of Employees | 18 | ||||
| Beta | 2.68 | ||||
| Market Capitalization | 14.86 M | ||||
| Total Asset | 21.12 M | ||||
| Retained Earnings | (274.39 M) | ||||
| Working Capital | (2.96 M) | ||||
| Current Asset | 3.84 M | ||||
| Current Liabilities | 840.05 K | ||||
| Z Score | -23.07 | ||||
| Net Asset | 21.12 M |
About Eloxx Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eloxx Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eloxx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eloxx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Eloxx Pink Sheet
If you are still planning to invest in Eloxx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eloxx Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |